Aidoc vs Subtle Medical
Two of the strongest records in imaging AI doing entirely different jobs, which is worth stating because they compete for the same budget. Aidoc finds things: an operating system running detection models across an imaging estate, with a January 2026 clearance spanning many acute indications from one named foundation model and regulator reviewed performance figures behind it. Subtle changes how the image looks: deep learning reconstruction and denoising that lets a department scan faster or at lower dose on the scanners it already owns, with eleven clearances and more than 25 publications. The budget question is which constraint binds. If studies are read too late, Aidoc. If the scanner is the bottleneck and the waiting list is the problem, Subtle returns capacity without adding anything to the radiologist's read, and that is a different kind of win.
- The foundation model approach produced a clearance covering many acute indications at once, with regulator reviewed performance figures rather than a vendor benchmark behind them.
- The operating system handles normalisation, continuous performance monitoring and governance across every model it runs, which is the part a health system cannot build itself and the reason multi algorithm deployments usually fail.
- The data handling model is published in unusual detail, with de identification performed before upload, which changes the health privacy question architecturally rather than contractually.
- It does not detect anything, which is the point: enhancement raises image quality or cuts scan time on scanners the department already owns, so the benefit is throughput rather than a new finding.
- A reported eleven clearances across two modalities with more than 25 peer reviewed publications, and a published standards based integration specification.
- The economics are different in kind. Detection AI adds work to the read; enhancement takes time off the scanner, which is the constraint most imaging departments are actually managing.
Side by Side
| Axis | A Aidoc |
S Subtle Medical |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Radiology & Imaging AI page.
These products do different jobs and a department may well buy both, so the comparison is about which constraint binds rather than which vendor wins. Their failure modes are opposite and both are easy to miss: a triage model that degrades quietly returns worklists to their usual order, while a reconstruction model that degrades produces cleaner images that have lost something, and only the second is invisible to the reader. Neither vendor publishes pricing.
Subtle publishes no subgroup performance and its attestation is under specified; Aidoc claims its own certification with an annually certified management system, which is the stronger position of the two.